These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 5824263

  • 1. [Rate of survival in prostatic cancer with bone metastasis].
    Kuntz D, Ryckewaert A.
    Rev Fr Etud Clin Biol; 1969; 14(6):609-13. PubMed ID: 5824263
    [No Abstract] [Full Text] [Related]

  • 2. Biologic and pathophysiologic prognosticating indices in prostatic cancer.
    Madduri SD, Sporer A, Seebode JJ.
    Am Surg; 1978 May; 44(5):290-5. PubMed ID: 666117
    [No Abstract] [Full Text] [Related]

  • 3. Endocrine treatment of cancer of the prostate.
    Madsen PO, Pedersen JF, Knuth OE.
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract] [Full Text] [Related]

  • 4. Prostatic carcinoma treated at categorical center: clinical and pathologic observations.
    Schoonees R, Palma LD, Gaeta JF, Moore RH, Murphy GP.
    N Y State J Med; 1972 May 01; 72(9):1021-7. PubMed ID: 4502386
    [No Abstract] [Full Text] [Related]

  • 5. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
    Breitwieser P, Nöske HD.
    Z Urol Nephrol; 1971 Apr 01; 64(4):249-56. PubMed ID: 5094006
    [No Abstract] [Full Text] [Related]

  • 6. [Endocrine therapy of prostatic cancer].
    Shimazaki J, Fuse H, Zama S.
    Gan No Rinsho; 1985 Jul 01; 31(9 Suppl):1195-201. PubMed ID: 4057576
    [Abstract] [Full Text] [Related]

  • 7. Prognosis of prostatic cancer.
    Arvola I, Lilius HG, Uusi-Penttilä S.
    Ann Chir Gynaecol Fenn; 1972 Jul 01; 61(1):25-9. PubMed ID: 5021539
    [No Abstract] [Full Text] [Related]

  • 8. [Prostatic cancer and acid phosphatase].
    Mischol HR.
    Schweiz Med Wochenschr; 1969 Sep 20; 99(38):1357-61. PubMed ID: 5349533
    [No Abstract] [Full Text] [Related]

  • 9. [Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
    Bracci U.
    J Urol Nephrol (Paris); 1973 Dec 20; 79(12 Pt 2):405-6. PubMed ID: 4804409
    [No Abstract] [Full Text] [Related]

  • 10. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T, Varkarakis MJ, Murphy GP.
    Ann Surg; 1974 Jan 20; 179(1):17-23. PubMed ID: 4817870
    [No Abstract] [Full Text] [Related]

  • 11. [Hormone therapy of prostatic cancer].
    Nilsson S.
    Lakartidningen; 1968 Jun 19; 65(25):2563-70. PubMed ID: 5720284
    [No Abstract] [Full Text] [Related]

  • 12. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J, Lorente JA, Reig C, López Pacios MA, de Torres JA, Soler Roselló A.
    Actas Urol Esp; 1994 May 19; 18(5):559-61. PubMed ID: 7521563
    [Abstract] [Full Text] [Related]

  • 13. Comparison of treatments for prostatic cancer using an exponential-type life model relating survival to concomitant information.
    Bayard S, Greenberg R, Showalter D, Byar D.
    Cancer Chemother Rep; 1974 May 19; 58(6):845-59. PubMed ID: 4447926
    [No Abstract] [Full Text] [Related]

  • 14. [Prostatic neoplasm with skeletal metastases. Exceptional survival and disappearance of the metastases after hormone therapy].
    Filippini U.
    Minerva Urol; 1969 May 19; 21(6):232-4. PubMed ID: 5403841
    [No Abstract] [Full Text] [Related]

  • 15. [Value of the determination of acid phosphatase of the blood in the diagnosis and prognosis of prostatic diseases. Comparisons of the results obtained with the technic of King and Jegatheesan and the technic of Babson and Read].
    Perrin J, Mallein R, Archimbaud JP, Boucherat M.
    Presse Med (1893); 1967 Sep 30; 75(40):1985-6. PubMed ID: 4168744
    [No Abstract] [Full Text] [Related]

  • 16. [Late results of treatment of prostatic cancer].
    Hanschke HJ, König K, Caspar W.
    Dtsch Med Wochenschr; 1968 Nov 22; 93(47):2271-4. PubMed ID: 5686345
    [No Abstract] [Full Text] [Related]

  • 17. [Prognosis and treatment of prostatic carcinoma].
    Klug W.
    Zentralbl Chir; 1968 Mar 09; 93(10):362-6. PubMed ID: 5674208
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [POSSIBILITIES OF "GUIDED" ENDOCRINE-SURGICAL TREATMENT IN CANCER OF THE PROSTATE].
    GIANNONI R, ZINI S, MARCELLI G.
    Arch Ital Urol; 1964 Apr 09; 36():423-40. PubMed ID: 14146744
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.